What is perineural injection therapy, including its indications, recommended ultrasound‑guided technique, medication regimen, contraindications, complications, and next steps if it fails?

Perineural Injection Therapy (PIT): Definition, Technique, and Clinical Application

Perineural injection therapy is an ultrasound-guided procedure that uses various injectates (corticosteroids, local anesthetics, 5% dextrose in water, or platelet-rich plasma) to mechanically release and decompress entrapped peripheral nerves through hydrodissection, providing both diagnostic and therapeutic benefit for peripheral nerve entrapment syndromes. 1

What It Is

Perineural injection therapy involves real-time ultrasound visualization to accurately target peripheral nerves and inject therapeutic agents directly around the nerve to achieve mechanical decompression and symptom relief. 2 The technique allows simultaneous assessment of structural abnormalities including nerve thickening, perineural scarring, subluxation, ganglion cysts, or neuromas that may contribute to neuropathic symptoms. 3, 2

Primary Indications

• Carpal tunnel syndrome (most extensively studied indication) 1, 4
• Ulnar neuropathy at the elbow 2, 1
• Foot and ankle nerve entrapments, including:
  • Hallux branch of medial plantar nerve (most common in foot/ankle series) 3
  • Sural, superficial and deep peroneal nerves 3
  • Medial and lateral plantar nerves 3
  • Posterior tibial nerve 3
• Upper extremity nerve entrapments, including median, ulnar, radial, posterior interosseous, and anterior interosseous nerves 2

Ultrasound-Guided Technique

Needle Positioning Strategy

For most peripheral nerves, single-sided needle placement at the deep surface produces adequate circumferential coverage of the nerve with standard injection volumes. 5

• Upper extremity nerves (radial, ulnar): Position needle deep to the nerve; 2 mL volume achieves 100% circumferential distribution with average spread of 11.6 cm 5
• Sciatic nerve: Position needle deep to the nerve; 5 mL volume achieves 100% circumferential distribution with average spread of 10.3 cm 5
• Median nerve in carpal tunnel (critical exception): Position needle between the nerve and flexor retinaculum (superficial to nerve) rather than deep to achieve reliable circumferential coverage 5

Procedural Approach

• Image guidance is mandatory to confirm correct needle position and identify structural abnormalities 2
• Real-time ultrasound allows tailoring of the procedure to potentially symptomatic structural abnormalities 2
• The injection site can be either perineural (directly adjacent to nerve) or peritendinous (among flexor tendons away from nerve)—both approaches show equivalent efficacy 4

Medication Regimens

Evidence-Based Injectate Options

Both 5% dextrose in water (D5W) and platelet-rich plasma (PRP) demonstrate consistently favorable outcomes compared to control groups or corticosteroids for sustained benefit. 1

• Corticosteroids (e.g., methylprednisolone acetate 40 mg): Proven effective with improvement maintained up to 12 weeks, though local side effects may occur 4
• 5% dextrose in water (D5W): Shows consistently favorable outcomes with excellent safety profile 1
• Platelet-rich plasma (PRP): Demonstrates superior long-term outcomes compared to corticosteroids 1
• Normal saline: Effective through mechanical hydrodissection alone 1
• Local anesthetics (e.g., 1% trimecaine hydrochloride 1 mL): Often combined with corticosteroids; provides immediate diagnostic confirmation 4

Volume Recommendations

• Upper extremity nerves: 2 mL typical volume 5
• Lower extremity/larger nerves: 5 mL typical volume 5

Contraindications

While the provided evidence does not explicitly list contraindications for perineural injection therapy specifically, standard precautions for any injection procedure apply, including:

• Active infection at injection site
• Allergy to injectate components
• Anticoagulation (relative contraindication requiring risk-benefit assessment)

Complications and Safety Profile

Perineural injection therapy demonstrates an excellent safety profile with minimal complications across multiple large case series. 3, 2

• Complication rate: Extremely low—only 1 complication in 59 injections (1.7%) in one series 3, and no site-specific complications in 242 procedures in another 2
• Vasovagal reactions: Reported in 3 of 242 cases (1.2%), representing the most common adverse event 2
• Local steroid side effects: Reported in isolated cases when corticosteroids used 1
• No serious adverse events reported across systematic review of multiple studies 1

Expected Outcomes

Immediate Response

• 96% of patients report immediate symptom relief following injection, serving as diagnostic confirmation 3
• Immediate pain relief provides prognostic information about potential benefit from surgical intervention 2

Sustained Relief

• 61% achieve interval symptom relief when follow-up data available 3
• Relief duration averages 125 days among responders 2
• Complete resolution occurs in approximately 6-7% of cases 2
• Both subjective (pain, function) and objective measures (two-point discrimination, grip strength, nerve cross-sectional area, distal motor latency) show improvement maintained through 12 weeks 4

Next Steps When Therapy Fails

Surgical Referral Considerations

Patients who fail perineural injection therapy should be considered for surgical intervention, though response to injection does not perfectly predict surgical candidacy. 2

• Among patients proceeding to surgery: 12 had experienced symptom relief from injection, while 20 had not 2
• Lack of response to injection does not preclude surgical benefit
• Positive response to injection confirms the nerve as symptom generator, supporting surgical decision-making

Repeat Injection Strategy

• Repeat injections are reasonable for patients who achieved temporary benefit 2
• 39 of 183 patients (21%) in one series underwent repeat injections of previously documented symptom generators 2

Integration with Multimodal Pain Management

Perineural injections should be incorporated as part of a multimodal treatment approach rather than used in isolation. 6 Consider:

• Physical therapy and rehabilitation
• Neuropathic pain medications for radicular symptoms 7
• Splinting or activity modification
• Referral to specialist pain services if symptoms persist beyond 3 months 7

Critical Pitfalls to Avoid

• Never perform blind injections—ultrasound guidance is essential for safety and efficacy 7
• Do not assume deep needle placement works for all nerves—the median nerve in the carpal tunnel requires superficial (between nerve and retinaculum) placement 5
• Do not delay referral for severe radicular pain—patients with disabling symptoms or neurological deficits should be referred within 2 weeks 7
• Avoid relying solely on imaging without clinical correlation—structural abnormalities on ultrasound (nerve thickening, scarring) are common but must correlate with clinical presentation 3, 2